Analysis of Hemoglobin Variants using an Automated Sample Preparation Workstation Coupled to LC-MS

Significance of the Topic

This study addresses the need for rapid, precise identification and quantification of hemoglobin variants, critical genetic markers in disorders such as sickle cell disease. Traditional immunoassays lack sufficient resolution and manual sample preparation can be time-consuming and variable. By automating sample handling and coupling directly to LC-MS, the workflow significantly improves throughput and analytical performance.

Objectives and Overview of the Study

The primary goal was to integrate immunoaffinity capture with online digestion and reversed-phase liquid chromatography, directly interfacing with mass spectrometry to streamline detection of normal and variant hemoglobin peptides in serum samples.

Methodology and Used Instrumentation

A Perfinity automated workstation executed five key proteomic steps—affinity selection, buffer exchange, trypsin digestion (under 4 minutes), desalting, and reversed-phase LC—within a one-hour workflow. Structural identification employed a Shimadzu LCMS-IT-TOF instrument, while quantitative assays used a Shimadzu LCMS-8030 triple quadrupole, leveraging selected ion monitoring (SIM) and multiple reaction monitoring (MRM).

Main Results and Discussion

The automated system reduced total sample prep time from 24 hours to under 1 hour, achieving 91% sequence coverage and process CVs below 10%. Separation of five key hemoglobin peptides, including the sickle cell variant marker VHLTPVEK, was achieved with baseline resolution. Quantitative reproducibility across three injections demonstrated RSDs typically under 5%, confirming the method’s robustness.

Benefits and Practical Applications

• High selectivity and resolution for distinguishing hemoglobin variants
• Substantial reduction in sample preparation time
• Improved reproducibility and assay precision (CV <10%)
• Applicability in clinical diagnostics, QA/QC, and research laboratories

Future Trends and Applications

Further development may include multiplexed MRM panels for broader variant screening, integration into high-throughput clinical platforms, miniaturized sample prep modules, and application of AI-driven data analysis for enhanced interpretation and decision support in personalized medicine.

Conclusion

The combination of automated sample preparation and sensitive LC-MS analysis provides a rapid, reproducible, and selective platform for hemoglobin variant characterization, offering significant advantages for both clinical and research applications.